Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: MSD-(Merck)

RUSSIA-BUSINESS/
RTS18HU9
June 24, 2017
The logo of pharmaceutical company Merck Sharp & Dohme Limited (MSD) is seen on a board at the St. Petersburg...
St. Petersburg, Russia
The logo of MSD pharmaceutical company is seen on a board at the SPIEF 2017 in St. Petersburg
The logo of pharmaceutical company Merck Sharp & Dohme Limited (MSD) is seen on a board at the St. Petersburg International Economic Forum 2017 (SPIEF 2017) in St. Petersburg, Russia, June 1, 2017. Picture taken June 1, 2017. REUTERS/Sergei Karpukhin
Business
Business
Merck Buys Schering-Plough For $41 Billion - 10 Mar 2009
16 PICTURES
SCHERINGPLOUGH-MERCK/
RTXCK2X
March 09, 2009
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would...
Linden, UNITED STATES
A view of the Merck & Co. campus in Linden, New Jersey
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky (UNITED STATES BUSINESS HEALTH)
SCHERINGPLOUGH-MERCK/
RTXCK2R
March 09, 2009
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would...
Linden, UNITED STATES
A view of the Merck & Co. campus in Linden, New Jersey
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. ÊREUTERS/Jeff Zelevansky (UNITED STATES BUSINESS HEALTH)
SCHERINGPLOUGH-MERCK/
RTXCK2M
March 09, 2009
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would...
Linden, UNITED STATES
A view of the Merck & Co. campus in Linden, New Jersey
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky (UNITED STATES BUSINESS HEALTH)
SCHERINGPLOUGH MERCK/
RTXCJUL
March 09, 2009
A sample of the drug Singulair made by Merck & Co. Inc. is seen in New York March 9, 2009. Merck & Co...
New York, UNITED STATES
A sample of the drug Singulair
A sample of the drug Singulair made by Merck & Co. Inc. is seen in New York March 9, 2009. Merck & Co Inc announced it would acquire Schering-Plough Corp for $41 billion, uniting the makers of cholesterol drugs Zetia and Vytorin in the second megadeal for Big Pharma in weeks. REUTERS/Chip East (UNITED STATES HEALTH BUSINESS)
THAILAND-DRUGS/
RTR1MI36
February 17, 2007
Efavirenz, a HIV-AIDS drug by Merck & Co., is photographed at the Phrabat Nampu Temple in Thailand's...
Bangkok, Thailand
Efavirenz, a HIV-AIDS drug by Merck & Co., is photographed at the Phrabat Nampu Temple in Thailand's...
Efavirenz, a HIV-AIDS drug by Merck & Co., is photographed at the Phrabat Nampu Temple in Thailand's Lopburi Province February 17, 2007. MercK & Co. announced on Thursday price cuts for Efavirenz, in poor countries and those hard hit by the disease, including Thailand, which plans to make a copycat version of the medicine. REUTERS/Adrees Latif (THAILAND)
Sort by
Display
Items per page
Page
of 1